Lyka Labs (BOM:500259) Operating Cash Flow per Share : ₹0.00 (TTM As of Dec. 2023)

View and export this data going back to 1992. Start your Free Trial

What is Lyka Labs Operating Cash Flow per Share?

Lyka Labs's operating cash flow per share for the three months ended in Dec. 2023 was ₹0.00. Lyka Labs's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 18.50% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 6.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Lyka Labs's Operating Cash Flow per Share or its related term are showing as below:

BOM:500259' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -53.3 Med: 4.9 Max: 82.6
Current: 18.5

During the past 13 years, Lyka Labs's highest 3-Year average Operating Cash Flow per Share Growth Rate was 82.60% per year. The lowest was -53.30% per year. And the median was 4.90% per year.

BOM:500259's 3-Year OCF Growth Rate is ranked better than
66.61% of 1240 companies
in the Biotechnology industry
Industry Median: 3.5 vs BOM:500259: 18.50

Lyka Labs Operating Cash Flow per Share Historical Data

The historical data trend for Lyka Labs's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lyka Labs Operating Cash Flow per Share Chart

Lyka Labs Annual Data

Trend

Mar13

Jun14

Jun15

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Operating Cash Flow per Share

Get a 7-Day Free Trial

9.36

1.87

3.07

27.62

3.11

Lyka Labs Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Lyka Labs's Operating Cash Flow per Share

For the Biotechnology subindustry, Lyka Labs's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lyka Labs's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lyka Labs's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Lyka Labs's Price-to-Operating-Cash-Flow falls into.

Lyka Labs Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Lyka Labs's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2023 is calculated as

Operating Cash Flow per Share (A: Mar. 2023 )	=	Cash Flow from Operations (A: Mar. 2023 )	/	Shares Outstanding (Diluted Average) (A: Mar. 2023 )
	=	89.526	/	28.783
	=	3.11

Lyka Labs's Operating Cash Flow per Share for the quarter that ended in Mar. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	0	/	33.604
	=	0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00

Lyka Labs Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Lyka Labs's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Lyka Labs (BOM:500259) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lyka Labs Ltd (BOM:500259) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

LYKALABS:India

Address

30, Forjett Street, Near Bhatia Hospital, Ground floor, Spencer Building (Block B & C), Grant Road (West), Mumbai, MH, IND, 400036

Website

http://www.lykalabs.com

Lyka Labs Ltd is an Indian biotechnology company. It mainly engages in the development of specialized formulations. The Company is engaged in only one segment viz. pharmaceuticals. The Company has presence in Domestic as well as International markets. The commercialized formulations of the company consist of hair care, anti-aging, acne management, skin lightening, face washes, sunscreens, facial scrubs, and others. It has developed a varied drug delivery system for topical steroids, painkillers, anti-fungal, and other emollients as well as liquid injectables, lyophilized injectables in the anti-bacterial, antifungal segment. The company also manufactures proton pump inhibitors, antibiotics, antifungals, steroids, etc. The majority of the company's revenue comes from India.

Lyka Labs (BOM:500259) Headlines

No Headlines